Glutathione-responsive nanoplatforms trigger gaseous intervention of intestinal inflammation through TLR4/MD2/MyD88/NF-κB/iNOS pathway activation and gut microbiota modulation
-
Published:2024-08
Issue:
Volume:493
Page:152849
-
ISSN:1385-8947
-
Container-title:Chemical Engineering Journal
-
language:en
-
Short-container-title:Chemical Engineering Journal
Author:
Li Yanfei, Zhu Beiwei, Chen Tao, Chen Lihang, Wu Di, Wang Xinchuang, Li Dongmei, Li Wei, Sun Yinshi, Hu JiangningORCID
Reference97 articles.
1. Manipulating the microbiome with fecal transplantation to treat ulcerative colitis;Kelly;J. Am. Med. Assoc.,2019 2. Breaking the therapeutic ceiling in drug development in ulcerative colitis;Alsoud;Gastroenterol. Hepatol.,2021 3. Ulcerative colitis;Ungaro;Lancet,2017 4. R. Wang, K. Guo, W. Zhang, Y. aHe, K. Yang, Q. Chen, L. Yang, Z. Di, J. Qiu, P. Lei, Y. Gu, Z. Luo, X. Xu, Z. Xu, X. Feng, S. Li, Z. Yu, H. Xu, Poly-γ-glutamic acid microgel-encapsulated probiotics with gastric acid resistance and smart inflammatory factor targeted delivery performance to ameliorate colitis. Adv. Funct. Mater. 32 (2022) 2113034. 5. Gut microbiota-derived inosine from dietary barley leaf supplementation attenuates colitis through PPARγ signaling activation;Li;Microbiome.,2021
|
|